Clinical Trials Logo

Acne Vulgaris clinical trials

View clinical trials related to Acne Vulgaris.

Filter by:

NCT ID: NCT04080869 Completed - Clinical trials for Facial Acne Vulgaris

Retinyl Palmitate-loaded Ethosomes in Acne Vulgaris

Start date: January 6, 2020
Phase: Phase 2
Study type: Interventional

Acne is a chronic inflammatory dermatosis of the pilosebaceous unit. Topical treatment is the first choice in mild and moderate cases of acne, especially topical retinoids. Although topical retinoids are very effective in the treatment of acne, local cutaneous irritation including burning, itching, erythema, peeling or dryness, is observed in a considerable number of patients, resulting in low patient compliance, compromising the efficacy of the therapy. Several approaches have been proposed to address these concerns, including the use of esters of retinoic acid (RA) and RA precursors, such as retinol and retinaldehyde, or novel drug delivery systems, which present the potential for controlled release, in turn reducing the aforementioned occurrences. Encapsulation of retinoids into vesicular carriers as liposomes and ethosomes and nanoparticulate carriers can significantly improve their effects for the treatment of acne compared with commercial formulations , providing better tolerability of irritating retinoid. The aim of work is to assess the efficacy and tolerability of the topical application of Retinyl Palmitate-loaded ethosome formulation in the treatment of acne vulgaris in comparison to conventional formulation of classic retinoids

NCT ID: NCT04059523 Completed - Acne Vulgaris Clinical Trials

MUSE Study to Evaluate the Pharmacokinetics, Safety and Tolerability of S6G5T-3

Start date: June 27, 2019
Phase: Phase 1
Study type: Interventional

To assess the degree of systemic exposure of S6G5T-3 compared to the Reference Listed Drug (RLD) Retin-A® 0.1% Cream when applied topically once daily for 14 days, under maximal use conditions in adolescents ≥12 years of age and adults with acne vulgaris.

NCT ID: NCT04057768 Completed - Wrinkle Clinical Trials

Fractional Radiofrequency for the Treatment and Reduction of Acne Scars and Wrinkles

Start date: August 19, 2019
Phase: N/A
Study type: Interventional

The objective of this clinical study is to evaluate the efficacy of fractional RF for the treatment and reduction of acne scarring or facial wrinkles.

NCT ID: NCT04056598 Completed - Acne Vulgaris Clinical Trials

Acne Vulgaris Related Microbiology and Serology

Start date: January 18, 2018
Phase:
Study type: Observational

This will be an investigation to determine the quality of the serological immune responses against Propionibacterium acnes (P. acnes) in acne patients compared to healthy individuals. In particular, the investigators will measure serum antibody titers against P. acnes surface antigens, and the efficiency of antibody-mediated phagocytic killing of P. acnes.

NCT ID: NCT04045119 Completed - Cosmetic Acne Clinical Trials

Effect of a Facial Cream Containing Cannabidiol and Hemp Oil on Skin Hydration and Acne-prone Skin

Dahlia
Start date: October 1, 2019
Phase: N/A
Study type: Interventional

This research seeks to evaluate the short (i.e., after single application) and long-term (i.e., after periodic application) hydrating effect of a topical preparation containing CBD and hemp oil on facial skin as well as the effect on erythema, appearance, instrumentally measured sebum production and quality of life.

NCT ID: NCT04044898 Completed - Acne Vulgaris Clinical Trials

Pharmacokinetics and Safety of ALA in Acne Vulgaris

Start date: January 12, 2021
Phase: Phase 1
Study type: Interventional

This study will evaluate the pharmacokinetics and safety of ALA in patients with moderate and severe acne vulgaris after single dose in different dosages.

NCT ID: NCT04018885 Completed - Acne Vulgaris Clinical Trials

A Study on Safety and Preliminary Efficacy of ALA in Acne Vulgaris

Start date: July 11, 2019
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to explore the safety, tolerability, and preliminary efficacy of ALA used with photodynamic therapy for the treatment of moderate to severe acne vulgaris.

NCT ID: NCT04015375 Completed - Acne Vulgaris Clinical Trials

Study Comparing Test to Aczone 7.5% and Both to a Placebo Control in the Treatment of Acne Vulgaris

Start date: July 11, 2019
Phase: Phase 3
Study type: Interventional

To evaluate the therapeutic effect of Dapsone and Placebo gel in the treatment of acne vulgaris.

NCT ID: NCT04002024 Completed - Acne Vulgaris Clinical Trials

Moisturizer Containing Licochalcone A, Decanediol, L-carnitine and Salicylic Acid in Reducing Relapsing of Acne

Start date: June 1, 2019
Phase: N/A
Study type: Interventional

Moisturizer containing the active ingredients of licochalcone A, decanediol, L-carnitine, and salicylic acid may be beneficial in alternative treatment of acne in maintenance phase. This study aims to evaluate the efficacy and safety of moisturizer containing the active ingredients of licochalcone A, decanediol, L-carnitine, and salicylic acid during the maintenance phase of acne in Thai patients.

NCT ID: NCT03938467 Completed - Clinical trials for Rate of Positive Culture Growth for C.Acnes From Specimens Obtained From the Shoulders of Patients Undergoing Primary Shoulder Arthroplasty

Irrisept C.Acnes Study

Start date: March 1, 2021
Phase: Phase 4
Study type: Interventional

A Prospective, Randomized, Controlled Trial Comparing An Irrisept Antiseptic Irrigation With 0.05% Chlorhexidine Gluconate versus Standard of Care Prophylaxis Chlorohexidine Wipes